FMP
GSK icon

Financial Management Professionals’s GSK GSK Stock Holding History

Financial Management Professionals’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
342
+28
+9% +$1.48K ﹤0.01% 479
2026
Q1 		$17.4K Buy
314
+159
+103% +$8.62K ﹤0.01% 437
2025
Q4 		$7.67K Hold
155
– – ﹤0.01% 568
2025
Q3 		$6.76K Hold
155
– – ﹤0.01% 567
2025
Q2 		$6.06K Sell
155
-93
-38% -$3.55K ﹤0.01% 607
2025
Q1 		$9.61K Buy
248
+51
+26% +$1.87K ﹤0.01% 532
2024
Q4 		$6.66K Buy
197
+176
+838% +$6.34K ﹤0.01% 574
2024
Q3 		$1K Sell
21
-3
-13% -$123 ﹤0.01% 834
2024
Q2 		$1K Buy
24
+8
+50% +$337 ﹤0.01% 789
2024
Q1 		$1K Sell
16
-134
-89% -$5.53K ﹤0.01% 853
2023
Q4 		$6K Buy
+150
New +$5.38K ﹤0.01% 631
2023
Q2 		– Sell
-127
Closed -$5K – 995
2023
Q1 		$5K Buy
127
+43
+51% +$1.5K ﹤0.01% 681
2022
Q4 		$3K Sell
84
-10
-11% -$333 ﹤0.01% 686
2022
Q3 		$3K Sell
94
-52
-36% -$1.97K ﹤0.01% 676
2022
Q2 		$8K Buy
146
+28
+24% +$1.55K ﹤0.01% 535
2022
Q1 		$6K Buy
118
+39
+49% +$2.12K ﹤0.01% 603
2021
Q4 		$4K Hold
79
– – ﹤0.01% 611
2021
Q3 		$4K Hold
79
– – ﹤0.01% 615
2021
Q2 		$4K Sell
79
-44
-36% -$2.11K ﹤0.01% 557
2021
Q1 		$5K Sell
123
-1,275
-91% -$57.9K ﹤0.01% 475
2020
Q4 		$64K Buy
1,398
+60
+4% +$2.76K 0.02% 191
2020
Q3 		$63K Sell
1,338
-303
-18% -$15.2K 0.02% 169
2020
Q2 		$84K Buy
1,641
+1,294
+373% +$66.4K 0.03% 122
2020
Q1 		$16K Hold
347
– – 0.01% 147
2019
Q4 		$20K Buy
347
+3
+0.9% +$167 0.01% 146
2019
Q3 		$18K Buy
+344
New +$17.7K 0.01% 147
2016
Q3 		– Sell
-265
Closed -$14K – 347
2016
Q2 		$14K Buy
+265
New +$14K 0.01% 172

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Financial Management Professionals's GSK Position: Q2 2026 in Review

Financial Management Professionals increased its GSK (GSK) stake by 8.9% in Q2 2026, buying an estimated $1.48K and bringing the position to 342 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Financial Management Professionals first reported a position in GSK in Q2 2016 and has held it in 27 quarters since. The position peaked at $84K in Q2 2020. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Financial Management Professionals held 342 shares of GSK worth $18.1K as of Q2 2026.
  • Financial Management Professionals bought 28 GSK shares in Q2 2026, an estimated $1.48K.
  • GSK made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #479 holding.
  • Financial Management Professionals first reported a position in GSK in Q2 2016 and has held it in 27 quarters since.
  • Financial Management Professionals's GSK position peaked at $84K in Q2 2020.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.